DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Design of a magnetic nanoplatform based on CD26 targeting and HSP90 inhibition for apoptosis and ferroptosis-mediated elimination of senescent cells
The accumulation of senescent cells, a hallmark of aging and age-related diseases, is also considered as a side effect of anticancer therapies, promoting drug resistance and leading to treatment failure. The use of senolytics, selective inducers of cell death in senescent cells, is a promising pharmacological antiaging and anticancer approach. However, more studies are needed to overcome the limitations of first-generation senolytics by the design of targeted senolytics and nanosenolytics and the validation of their usefulness in biological systems. In the present study, we have designed a nanoplatform composed of iron oxide nanoparticles functionalized with an antibody against a cell surface marker of senescent cells (CD26), and loaded with the senolytic drug HSP90 inhibitor 17-DMAG (MNP@CD26@17D). We have documented its action against oxidative stress-induced senescent human fibroblasts, WI-38 and BJ cells, and anticancer drug-induced senescent cutaneous squamous cell carcinoma A431 cells, demonstrating for the first time that CD26 is a valid marker of senescence in cancer cells. A dual response to MNP@CD26@17D stimulation in senescent cells was revealed, namely, apoptosis-based early response (2 h treatment) and ferroptosis-based late response (24 h treatment). MNP@CD26@17D-mediated ferroptosis might be executed by ferritinophagy as judged by elevated levels of the ferritinophagy marker NCOA4 and a decreased pool of ferritin. As 24 h treatment with MNP@CD26@17D did not induce hemolysis in human erythrocytes in vitro, this newly designed nanoplatform could be considered as an optimal multifunctional tool to target and eliminate senescent cells of skin origin, overcoming their apoptosis resistance., This work was supported by the National Science Centre (NCN, Poland) within M-ERA.NET 3 Call 2022 grant no. 2022/04/Y/ST5/00155 and PCI2023-143448 funded by MICIU/AEI/10.13039/501100011033 and cofunded by the European Union. Maria Moros acknowledges funding from the European Research Council (ERC) under the European Union’s Horizon 2020 Research and Innovation Programme (grant agreement no. 853468) and MCIN/AEI/10.13039/501100011033 and FSE+ (PID2021-122508NB-I00). S.D.S.-F. acknowledges financial support thanks to Marie Skłodowska-Curie Postdoctoral Fellowships (HORIZON-MSCA-2021-PF-01-01, grant agreement no. 101064735) funded by the European Union. The authors would like to acknowledge Fondo Social del Gobierno de Aragón (grupo DGA E15_23R), the use of Advanced Microscopy Laboratory (Universidad de Zaragoza), for access to their instrumentation and expertise, and the use of the Servicio General de Apoyo a la Investigación-SAI, Universidad de Zaragoza. The preliminary data that were helpful in the development of the research concept were obtained during a scientific stay of A.L. and M.W. in the Bionanosurf lab (Instituto de Nanociencia y Materiales de Aragón, Zaragoza, Spain). This article was also supported by the Polish National Agency for Academic Exchange under the NAWA STER programme - Internationalisation of Doctoral Schools No BPI/STE/2023/1/00001/DEC/01 to Julia Słaby (Open Access fee)., Peer reviewed, Modelo experimental alternativo-NAM, in vitro - Tipos celulares - líneas estables humanas, in vitro - Tipos celulares - líneas celulares primarias, in vitro - Sistemas de cultivo - Cultivos 2D, in vitro - Sistemas de cultivo - Cultivos 2D - Cultivo 2D sin fluídica